Which factor contributes to pharmacokinetic changes commonly observed with aging?

Which factor contributes to pharmacokinetic changes commonly observed with aging?

• A. The percentage of body fat
• B. Lean body mass
• C. Renal function
• D. Cardiac output

Answer: (A)

As people age, body composition shifts toward more fat and less lean mass. This increase in fat percentage expands the volume of distribution for fat-soluble drugs. When a drug distributes into fat tissue, it stays in the body longer, leading to a longer elimination half-life and a greater risk of accumulation with repeated dosing. That’s a common, pervasive pharmacokinetic change seen in older adults, which is why the fat percentage is the key factor here. Other factors do play roles in aging pharmacokinetics—lean body mass decreases, which can affect distribution of water-soluble drugs; renal function often declines, reducing drug clearance; and cardiac output can alter tissue perfusion affecting distribution and elimination. But the most universal and impactful change across many medications is the increased fat mass that alters distribution and prolongs drug effects.

As people age, body composition shifts toward more fat and less lean mass. This increase in fat percentage expands the volume of distribution for fat-soluble drugs. When a drug distributes into fat tissue, it stays in the body longer, leading to a longer elimination half-life and a greater risk of accumulation with repeated dosing. That’s a common, pervasive pharmacokinetic change seen in older adults, which is why the fat percentage is the key factor here.

Other factors do play roles in aging pharmacokinetics—lean body mass decreases, which can affect distribution of water-soluble drugs; renal function often declines, reducing drug clearance; and cardiac output can alter tissue perfusion affecting distribution and elimination. But the most universal and impactful change across many medications is the increased fat mass that alters distribution and prolongs drug effects.